A figure presented at ENDO 2026 in Chicago has stayed with me for weeks. In the largest claims analysis of its kind, researchers tracked more than 60,000 adults who started a GLP-1 for type 2 diabetes. By the two-year mark, most had stopped at some point. Here is the part our industry tends to skip […]
Read more
Three new research signals reveal a widening chasm between prescription intent and patient action, and point toward what actually closes it. Every day, physicians write prescriptions that patients never fill. Some never even pick them up. Others start, stop, and disappear from therapy within 90 days. The clinical encounter works. The commercial infrastructure behind it […]
Read more
What Happens When You Shut Down a Call Center Without a Plan? Pharmaceutical patient services teams are under immense pressure. Costs are rising. Staffing is unstable. Call center turnover is high. And leadership teams are being asked a difficult question: “Can we afford to keep this call center running?” But there is a far more […]
Read more